| Product Code: ETC12838510 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Influenza B Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Influenza B Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Influenza B Market - Industry Life Cycle |
3.4 Taiwan Influenza B Market - Porter's Five Forces |
3.5 Taiwan Influenza B Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Taiwan Influenza B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Taiwan Influenza B Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
3.8 Taiwan Influenza B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Taiwan Influenza B Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing influenza B |
4.2.2 Government initiatives promoting influenza B vaccination programs |
4.2.3 Technological advancements in influenza diagnostics and treatment |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 Seasonal nature of influenza outbreaks leading to fluctuating demand |
4.3.3 Potential side effects or misconceptions about influenza B vaccines |
5 Taiwan Influenza B Market Trends |
6 Taiwan Influenza B Market, By Types |
6.1 Taiwan Influenza B Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Influenza B Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Taiwan Influenza B Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Baloxavir), 2021 - 2031F |
6.1.4 Taiwan Influenza B Market Revenues & Volume, By Symptom Management (Pain Relievers, Antihistamines), 2021 - 2031F |
6.2 Taiwan Influenza B Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Influenza B Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Taiwan Influenza B Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 Taiwan Influenza B Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 Taiwan Influenza B Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Influenza B Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Taiwan Influenza B Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Taiwan Influenza B Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 Taiwan Influenza B Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Influenza B Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Taiwan Influenza B Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Taiwan Influenza B Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Taiwan Influenza B Market Import-Export Trade Statistics |
7.1 Taiwan Influenza B Market Export to Major Countries |
7.2 Taiwan Influenza B Market Imports from Major Countries |
8 Taiwan Influenza B Market Key Performance Indicators |
8.1 Rate of influenza B vaccination coverage in Taiwan |
8.2 Number of healthcare facilities offering influenza B vaccination services |
8.3 Percentage of population receiving timely influenza B diagnosis and treatment |
9 Taiwan Influenza B Market - Opportunity Assessment |
9.1 Taiwan Influenza B Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Taiwan Influenza B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Taiwan Influenza B Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
9.4 Taiwan Influenza B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Taiwan Influenza B Market - Competitive Landscape |
10.1 Taiwan Influenza B Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Influenza B Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here